Startups
Ovarian Cancer Research Alliance (OCRA) is the largest global organization dedicated to fighting ovarian cancer. OCRA advances research to prevent, treat and defeat ovarian cancer, supports women and their families before, during and beyond diagnosis, and works with all levels of government to ensure ovarian cancer is a priority.
As the largest private funder of ovarian cancer research, OCRA invests in innovative, promising research. And OCRA is the voice for the ovarian cancer community: fighting for more resources and policies on Capitol Hill, helping future health professionals recognize the disease through our Survivors Teaching Students® program, providing hope and insight by pairing newly diagnosed patients with our Woman to Woman program and connecting survivors at our Ovarian Cancer National Conference. We are united to defeat ovarian cancer. Visit ocrahope.org to learn more.
As the largest private funder of ovarian cancer research, OCRA invests in innovative, promising research. And OCRA is the voice for the ovarian cancer community: fighting for more resources and policies on Capitol Hill, helping future health professionals recognize the disease through our Survivors Teaching Students® program, providing hope and insight by pairing newly diagnosed patients with our Woman to Woman program and connecting survivors at our Ovarian Cancer National Conference. We are united to defeat ovarian cancer. Visit ocrahope.org to learn more.
Overview
Location
United States, New York
Employees
11-50
Phone
+1 212-268-1002
Total raised
$5M
Founded date
1994
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 17, 2025 | Ovarian Cancer Research Alliance Partners with Iris by OncoHealth to Expand Access to the Steps Counseling Program | Iris by OncoHealth & Ovarian Cancer Research Alliance Partners New collaboration enhances support for gynecologic cancer patients through integrated digital and personalized care NEW YORK, June 17, 2025 /PRNewswire-PRWeb/ -- Ovarian Can... |
| Sep 3, 2024 | Ovarian Cancer Research Alliance (OCRA) Champions Access and Equity in Ovarian Cancer and Gynecologic Cancer Awareness Month | NEW YORK, Sept. 3, 2024 /PRNewswire/ -- As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is proud to highlight a series of initiatives aimed at expanding access and promoting equity in ovaria... |
| Mar 17, 2024 | I chose to be a single mom at 36 and had 3 kids. When I got cancer, I worried about what would happen if I died. | Parenting I chose to be a single mom at 36 and had 3 kids. When I got cancer, I worried about what would happen if I died. Allison Langer 2024-03-17T12:16:02Z Share icon An curved arrow pointing right. Share Facebook Icon The letter F. Face... |
| Mar 23, 2023 | Michael Clements Supports the Ovarian Cancer Research Alliance in Honor of Mother | Engineering executive Michael Clements has recently donated to the Ovarian Cancer Research Alliance in memory of his mother. NEW YORK, NY, UNITED STATES, March 23, 2023/EINPresswire.com/ -- Michael Clements, engineer executive and president... |
| Feb 23, 2023 | More physicians are calling for fallopian tube removal to prevent ovarian cancer | Ovarian cancer has long been one of the deadliest cancers to strike women. No tests are available to detect it early, so most patients are diagnosed in later stages, when the cancer is more likely to have spread. Fewer than half of women su... |
| Sep 13, 2022 | AOA Dx Closes $7 Million Funding Round To Bring The First Accurate Early Detection Test For Ovarian Cancer To Market | AOA teamAOA |
| Jan 5, 2022 | Taking notes from MD Anderson and Rice University, Avenge Bio uncloaks with $45M and a slate of immunotherapies | Omid Veiseh Michael Heffernan was already the head of a biotech company focused on chronic pain, called Collegium Pharmaceutical, which he successfully brought public in 2015. But when his wife was diagnosed with ovarian... |
| Sep 20, 2021 | Dignitana Honors Ovarian Cancer Survivor as a “DigniCap Dignitary” | Dignitana Honors Ovarian Cancer Survivor as a “DigniCap Dignitary” Mon, Sep 20, 2021 10:44 CET Lori Agostino Inspires Positivity and Perseverance During Ovarian Cancer Awareness Month Dignitana, world leader in scalp cooling innovation, has... |
| Aug 25, 2021 | Let's talk Lady Parts for Ovarian Cancer Awareness Month with President & CEO of OCRA, Audra Moran | NEW YORK, Aug. 25, 2021 /PRNewswire/ -- September is Ovarian Cancer Awareness month, and it's time to get comfortable talking Lady Parts. Every 23 minutes, someone in the US is diagnosed with ovarian cancer, killing 14,000 women each year. ... |
Show more
Reviews 0
FAQ about Ovarian Cancer Research Alliance
When was Ovarian Cancer Research Alliance founded?
Ovarian Cancer Research Alliance was founded in 1994.
How much funding has Ovarian Cancer Research Alliance raised?
Ovarian Cancer Research Alliance has raised $5M in total across 1 funding round.
What has the press written about Ovarian Cancer Research Alliance?
Parsers VC has collected 11 articles mentioning Ovarian Cancer Research Alliance, among them “Ovarian Cancer Research Alliance Partners with Iris by OncoHealth to Expand Access to the Steps Counseling Program” (Jun 17, 2025) and “Ovarian Cancer Research Alliance (OCRA) Champions Access and Equity in Ovarian Cancer and Gynecologic Cancer Awareness Month” (Sep 3, 2024).
Is Ovarian Cancer Research Alliance still active?
Yes, Ovarian Cancer Research Alliance is active; its latest activity on Parsers VC dates from Oct 10, 2025.